«Problematic relationship:
Small brain models distort contact intensity between neurons.»
Not exact matches
The system mimics the «homunculus
model of mind» — the idea that there's a
small human inside our
brains controlling our actions, viewing the images we see and understanding them for us.
In a
model of glioblastoma, a
brain cancer that does not metastasize outside of the
brain, they could readily see that the length of circulating tumor DNA was
smaller than healthy DNA by 20 - 50 base pairs.
An international team of researchers has shown that a new
small - molecule drug can restore
brain function and memory in a mouse
model of Alzheimer's disease.
In a novel animal study design that mimicked human clinical trials, researchers at University of California, San Diego School of Medicine report that long - term treatment using a
small molecule drug that reduces activity of the
brain's stress circuitry significantly reduces Alzheimer's disease (AD) neuropathology and prevents onset of cognitive impairment in a mouse
model of the neurodegenerative condition.
By using the
smaller and less complex cricket
brain as a
model, Dr. Adamo hopes to uncover more broad patterns of nervous system function in both immune responses and, of course, behavior.
Blocking this process with a
small - molecule drug prevented the characteristic
brain plaques and memory loss in a mouse
model of the disease.
In the March issue of Scientific American Carl Schoonover, author of Portraits of the Mind: Visualizing the
Brain from Antiquity to the 21st Century, describes a new computer - modeling technique that allows researchers to zoom in on the smallest components of the active brain in 3
Brain from Antiquity to the 21st Century, describes a new computer -
modeling technique that allows researchers to zoom in on the
smallest components of the active
brain in 3
brain in 3 - D.
Now, a study in the journal
Brain describes what could be considered a direct «aquarium - to - bedside» approach, taking a drug discovered in a genetic zebrafish
model of epilepsy and testing it, with promising results, in a
small number of children with the disease.
Their
model is the fruit fly, a master in motion vision, possessing a relatively
small brain.
iTeos is now developing EOS200271 which is a synthetic,
small molecule inhibitor of indoleamine 2,3 - dioxygenase (IDO1), which has demonstrated the same anti-tumour activity in multiple preclinical tumour
models in combination with immune checkpoint inhibitors as competitors, but also has demonstrated superior
brain penetration.
«This study provides proof - of - concept experiments, in large animal
models, that a
small, miniaturized device can be safely implanted in the
brain and provide miniaturized control of the electrical activity and function of single neurons or
small groups of neurons.
These plaques are extracellular aggregations of a
small protein called beta - amyloid that are prominent in diseased patients»
brains, as well as in mouse
models of the disease.
The core facility is a two - photon in vivo imaging platform developed at the Nonlinear bioimaging laboratory, a technique that allows for non-invasive structural and functional measurements in
small animal
models at different scales: from macroscopic imaging of the
brain morphology to highly resolved microscopy of neuron populations, single neurons, and even subcellular structures.